Pulmonary anthrax (Q66266): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed an Item
 
(6 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Antraz pulmonar começa abruptamente, geralmente 1-3 dias (variação, 1-60 dias) após a inalação dos esporos do antraz com 1-5 µm de diâmetro. O número de esporos necessários para causar o antraz pulmonar varia. Esta forma se apresenta inicialmente com sintomas inespecíficos, incluindo febre baixa e tosse não produtiva. Os pacientes podem relatar desconforto subesternal no início da doença. Os pacientes podem melhorar temporariamente antes de rápida deterioração clínica com mediastinite hemorrágica. Após a melhora inicial, o antraz por inalação progride rapidamente, causando febre alta, falta de ar grave, taquipneia, cianose, diaforese profusa, hematêmese e dor torácica, que pode ser grave o suficiente para mimetizar infarto agudo do miocárdio.
description / endescription / en
 
Pulmonary anthrax begins abruptly, usually 1-3 days (range, 1-60 d) after inhaling anthrax spores that are 1-5 µm in diameter. The number of spores needed to cause pulmonary anthrax varies. This form presents initially with nonspecific symptoms, including a low-grade fever and a nonproductive cough. Patients may report substernal discomfort early in the illness. Patients may improve temporarily before rapidly deteriorating clinically with haemorrhagic mediastinitis. After the initial improvement, inhalation anthrax progresses rapidly, causing high fever, severe shortness of breath, tachypnoea, cyanosis, profuse diaphoresis, hematemesis, and chest pain, which may be severe enough to mimic acute myocardial infarction.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/534877374 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_534877374
Property / CURIE: CID11:ID_534877374 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_534877374
Property / Canary Token: dki-india-ID_534877374 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 14:04, 14 August 2026

Pulmonary anthrax begins abruptly, usually 1-3 days (range, 1-60 d) after inhaling anthrax spores that are 1-5 µm in diameter. The number of spores needed to cause pulmonary anthrax varies. This form presents initially with nonspecific symptoms, including a low-grade fever and a nonproductive cough. Patients may report substernal discomfort early in the illness. Patients may improve temporarily before rapidly deteriorating clinically with haemorrhagic mediastinitis. After the initial improvement, inhalation anthrax progresses rapidly, causing high fever, severe shortness of breath, tachypnoea, cyanosis, profuse diaphoresis, hematemesis, and chest pain, which may be severe enough to mimic acute myocardial infarction.
Language Label Description Also known as
default for all languages
ID_534877374
    English
    Pulmonary anthrax
    Pulmonary anthrax begins abruptly, usually 1-3 days (range, 1-60 d) after inhaling anthrax spores that are 1-5 µm in diameter. The number of spores needed to cause pulmonary anthrax varies. This form presents initially with nonspecific symptoms, including a low-grade fever and a nonproductive cough. Patients may report substernal discomfort early in the illness. Patients may improve temporarily before rapidly deteriorating clinically with haemorrhagic mediastinitis. After the initial improvement, inhalation anthrax progresses rapidly, causing high fever, severe shortness of breath, tachypnoea, cyanosis, profuse diaphoresis, hematemesis, and chest pain, which may be severe enough to mimic acute myocardial infarction.

      Statements

      CID11:ID_534877374
      0 references
      dki-india-ID_534877374
      0 references
      Concluído
      0 references
      13 August 2026
      0 references